Results 131 to 140 of about 1,543,826 (299)

Cost‐effectiveness of second‐line therapies in adults with chronic immune thrombocytopenia

American Journal of Hematology, Volume 98, Issue 1, Page 122-130, January 2023., 2023
Abstract Major options for second‐line therapy in adults with chronic immune thrombocytopenia (ITP) include splenectomy, rituximab, and thrombopoietin receptor agonists (TRAs). The American Society of Hematology guidelines recommend rituximab over splenectomy, TRAs over rituximab, and splenectomy or TRAs while noting a lack of evidence on the cost ...
George Goshua, Pranay Sinha, Natalia Kunst, Lauren Pischel, Alfred Ian Lee, Adam Cuker   +5 more
wiley   +1 more source

Studies of the Microbiological Oxidation of Steroids by Cunninghamella blakesleeana H-334 [PDF]

, 1955
Kingsley M. Mann, Frederick R. Hanson, Paul W. O’Connell, Hugh V. Anderson, Mari P. Brunner, John N. Karnemaat   +5 more
openalex   +1 more source

Triarylphosphonium BODIPY‐Based [2]Rotaxanes Nanoparticles for Light‐Driven Antibacterial Applications

Advanced Optical Materials, EarlyView.
New photosensitizers for light‐induced antimicrobial therapy are successfully synthesized and characterized. When dissolved in water, all compounds self‐assemble forming spherical aggregates with <100 nm dimensions. The nanoparticles show high photothermal conversion efficiency and demonstrate antimicrobial activity toward both Gram‐negative and Gram ...
Greta Sambucari, Corinne Coutant, Alessandro Di Michele, Gina Elena Giacomazzo, Pierrick Nun, Vincent Sol, Noe Renard, Tan‐Sothea Ouk, Vincent Coeffard, Mariangela Di Donato   +9 more
wiley   +1 more source

Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T‐cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant

American Journal of Hematology, Volume 98, Issue 1, Page 159-165, January 2023., 2023
Donor stem cell product undergoes CD34 stem cell selection. CD34 positive stem cells are used for transplantation. Pathogen‐ and leukemia‐specific T‐cells are manufactured from CD34 negative fraction and infused prophylactically 21 days after transplant.
David J. Gottlieb, Gaurav Sutrave, Wei Jiang, Selmir Avdic, Janine A. Street, Renee Simms, Leighton E. Clancy, Vicki Antonenas, Brian S. Gloss, Caroline Bateman, David C. Bishop, Kenneth P. Micklethwaite, Emily Blyth   +12 more
wiley   +1 more source

Microbiological Studies of Cucumber Fermentations [PDF]

, 1953
Ralph N. Costilow, F. W. Fabian
openalex   +1 more source

Field Trials of Low‐Cost Bi‐TiO2‐P25 Solar Photo Catalyst for Water Treatment

Advanced Sustainable Systems, EarlyView.
Journey of a low‐cost and easy to synthesize catalyst from development to validation in laboratory, followed by testing for its ability to reduce total coliform and E. Coli in the real‐world water using solar light in rural India. Abstract A low‐cost, easy to make Bi‐TiO2‐P25 composite is synthesized via a reverse micelle sol‐gel route and is tested ...
Ayushi Arora, Victoria E. Porley, Bhim C. Meikap, Ramkrishna Sen, Ankita Debnath, Efthalia Chatzisymeon, Neil Robertson   +6 more
wiley   +1 more source

Retraction: Human gut microbiota: dysbiosis and manipulation

Frontiers in Cellular and Infection Microbiology, 2013
Frontiers in Microbiology
doaj   +1 more source

Antibiotic–Polycationic Peptide Conjugation as an Effective Strategy to Overcome Daptomycin Resistance

Advanced Therapeutics, EarlyView.
Antimicrobial resistance necessitates the development of new antibiotics with “resistance‐breaking” properties. In this study, conjugation of polycationic peptides is proven to represent a versatile strategy for the fast and affordable reactivation of daptomycin.
Sari Rasheed, Florian Umstätter, Eric Mühlberg, Barbro Beijer, Tobias Hertlein, Karel D. Klika, Christian Kleist, Julia Werner, Cornelius Domhan, Mara Bingel, Anna Müller, Marvin Rausch, Stefan Zimmermann, Knut Ohlsen, Uwe Haberkorn, Marcus Koch, Markus Bischoff, Tanja Schneider, Rolf Müller, Jennifer Herrmann, Walter Mier, Philipp Uhl   +21 more
wiley   +1 more source

Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti‐spike neutralizing IgG to SARS‐CoV‐2 variants, but preserved antigen‐specific T cell responses

American Journal of Hematology, Volume 98, Issue 1, Page 131-139, January 2023., 2023
Abstract Patients with indolent lymphoma undertaking recurrent or continuous B cell suppression are at risk of severe COVID‐19. Patients and healthy controls (HC; N = 13) received two doses of BNT162b2: follicular lymphoma (FL; N = 35) who were treatment naïve (TN; N = 11) or received immunochemotherapy (ICT; N = 23) and Waldenström's macroglobulinemia
Brendan Beaton, Sarah C. Sasson, Katherine Rankin, Juliette Raedemaeker, Alexander Wong, Priyanka Hastak, Chansavath Phetsouphanh, Andrew Warden, Vera Klemm, C. Mee Ling Munier, Alexandra Carey Hoppe, Fiona Tea, Aleha Pillay, Alberto Ospina Stella, Anupriya Aggarwal, Orly Lavee, Ian D. Caterson, Stuart Turville, Anthony D. Kelleher, Fabienne Brilot, Judith Trotman   +20 more
wiley   +1 more source

Retraction: Miki M and Katayama K (2012) In silico 3D structure analysis accelerates the solution of a real viral structure and antibodies docking mechanism. Front. Microbio. 3:387. doi: 10.3389/fmicb.2012.00387

Frontiers in Microbiology, 2015
Frontiers in Microbiology
doaj   +1 more source